Cargando…

Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme

Although rubella is usually a mild childhood disease, this infection in early pregnancy poses a serious problem due to its teratogenic effect. The goal of interrupted circulation and elimination of rubella virus was achieved in many countries in the world. The aim of this study was to determine the...

Descripción completa

Detalles Bibliográficos
Autores principales: Patić, Aleksandra, Štrbac, Mirjana, Petrović, Vladimir, Milošević, Vesna, Ristić, Mioljub, Hrnjaković Cvjetković, Ivana, Medić, Snežana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957133/
https://www.ncbi.nlm.nih.gov/pubmed/31929584
http://dx.doi.org/10.1371/journal.pone.0227413
_version_ 1783487263610503168
author Patić, Aleksandra
Štrbac, Mirjana
Petrović, Vladimir
Milošević, Vesna
Ristić, Mioljub
Hrnjaković Cvjetković, Ivana
Medić, Snežana
author_facet Patić, Aleksandra
Štrbac, Mirjana
Petrović, Vladimir
Milošević, Vesna
Ristić, Mioljub
Hrnjaković Cvjetković, Ivana
Medić, Snežana
author_sort Patić, Aleksandra
collection PubMed
description Although rubella is usually a mild childhood disease, this infection in early pregnancy poses a serious problem due to its teratogenic effect. The goal of interrupted circulation and elimination of rubella virus was achieved in many countries in the world. The aim of this study was to determine the status of rubella immunity in Vojvodina and evaluate Serbia’s progress toward this goal. A total of 3404 residual serum samples from patients of all ages (1 to 84 years) were included in the study. Samples were collected between May 2015 and December 2017 in Vojvodina. Rubella IgG antibodies were determined using an indirect chemiluminescent immunoassay. Percentage of participants seropositive for rubella antibodies was 92.9% in the entire sample. The highest number of seronegatives was in the youngest (1 year) age group (44.7%), followed by the group aged 24–49 (6.4%) and 2–11 years (6.2%). The absence of a higher percentage of children with protective anti-rubella antibodies in the group aged 2–11 can be explained by a lower immunization coverage during certain years. Participants in the group aged 24–49 were born during the pre-vaccination period with lower rubella incidence, leading to the conclusion that not all individuals of that age came into a contact with the virus. Comparing levels of anti-rubella IgG antibodies of seropositive males and females of different ages reveals that the immunity after a contact with the virus and a previously acquired infection is stronger than the immunity after the vaccination. Although the incidence rate of rubella in Vojvodina has been low for the last ten years, there is still a risk of an outbreak due to a decrease in immunization coverage. This study shows that the percentage of susceptible individuals is high, especially considering women aged 24–49, and that additional ("catch-up") immunization is required.
format Online
Article
Text
id pubmed-6957133
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-69571332020-01-26 Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme Patić, Aleksandra Štrbac, Mirjana Petrović, Vladimir Milošević, Vesna Ristić, Mioljub Hrnjaković Cvjetković, Ivana Medić, Snežana PLoS One Research Article Although rubella is usually a mild childhood disease, this infection in early pregnancy poses a serious problem due to its teratogenic effect. The goal of interrupted circulation and elimination of rubella virus was achieved in many countries in the world. The aim of this study was to determine the status of rubella immunity in Vojvodina and evaluate Serbia’s progress toward this goal. A total of 3404 residual serum samples from patients of all ages (1 to 84 years) were included in the study. Samples were collected between May 2015 and December 2017 in Vojvodina. Rubella IgG antibodies were determined using an indirect chemiluminescent immunoassay. Percentage of participants seropositive for rubella antibodies was 92.9% in the entire sample. The highest number of seronegatives was in the youngest (1 year) age group (44.7%), followed by the group aged 24–49 (6.4%) and 2–11 years (6.2%). The absence of a higher percentage of children with protective anti-rubella antibodies in the group aged 2–11 can be explained by a lower immunization coverage during certain years. Participants in the group aged 24–49 were born during the pre-vaccination period with lower rubella incidence, leading to the conclusion that not all individuals of that age came into a contact with the virus. Comparing levels of anti-rubella IgG antibodies of seropositive males and females of different ages reveals that the immunity after a contact with the virus and a previously acquired infection is stronger than the immunity after the vaccination. Although the incidence rate of rubella in Vojvodina has been low for the last ten years, there is still a risk of an outbreak due to a decrease in immunization coverage. This study shows that the percentage of susceptible individuals is high, especially considering women aged 24–49, and that additional ("catch-up") immunization is required. Public Library of Science 2020-01-13 /pmc/articles/PMC6957133/ /pubmed/31929584 http://dx.doi.org/10.1371/journal.pone.0227413 Text en © 2020 Patić et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Patić, Aleksandra
Štrbac, Mirjana
Petrović, Vladimir
Milošević, Vesna
Ristić, Mioljub
Hrnjaković Cvjetković, Ivana
Medić, Snežana
Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme
title Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme
title_full Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme
title_fullStr Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme
title_full_unstemmed Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme
title_short Seroepidemiological study of rubella in Vojvodina, Serbia: 24 years after the introduction of the MMR vaccine in the national immunization programme
title_sort seroepidemiological study of rubella in vojvodina, serbia: 24 years after the introduction of the mmr vaccine in the national immunization programme
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6957133/
https://www.ncbi.nlm.nih.gov/pubmed/31929584
http://dx.doi.org/10.1371/journal.pone.0227413
work_keys_str_mv AT paticaleksandra seroepidemiologicalstudyofrubellainvojvodinaserbia24yearsaftertheintroductionofthemmrvaccineinthenationalimmunizationprogramme
AT strbacmirjana seroepidemiologicalstudyofrubellainvojvodinaserbia24yearsaftertheintroductionofthemmrvaccineinthenationalimmunizationprogramme
AT petrovicvladimir seroepidemiologicalstudyofrubellainvojvodinaserbia24yearsaftertheintroductionofthemmrvaccineinthenationalimmunizationprogramme
AT milosevicvesna seroepidemiologicalstudyofrubellainvojvodinaserbia24yearsaftertheintroductionofthemmrvaccineinthenationalimmunizationprogramme
AT risticmioljub seroepidemiologicalstudyofrubellainvojvodinaserbia24yearsaftertheintroductionofthemmrvaccineinthenationalimmunizationprogramme
AT hrnjakoviccvjetkovicivana seroepidemiologicalstudyofrubellainvojvodinaserbia24yearsaftertheintroductionofthemmrvaccineinthenationalimmunizationprogramme
AT medicsnezana seroepidemiologicalstudyofrubellainvojvodinaserbia24yearsaftertheintroductionofthemmrvaccineinthenationalimmunizationprogramme